Oral cephalosporins in the treatment of respiratory tract infections

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 13 SUPPL. A, 1996, Pages 87-96

  Bergogne Bérézin, Eugénie ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE; CEFACETRILE; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFALOGLYCIN; CEFALOTIN; CEFAMANDOLE; CEFAPIRIN; CEFAZOLIN; CEFDINIR; CEFETAMET PIVOXIL; CEFIXIME; CEFOPERAZONE; CEFOTAXIME; CEFOTIAM; CEFOXITIN; CEFPODOXIME PROXETIL; CEFRADINE; CEFTAZIDIME; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; BACTERIOLOGY; COMMUNITY; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG STABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

EID: 0029808515     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80105-6     Document Type: Conference Paper

References (17)

1. Bryskier A. Classification des céphalosporines et relation activité-structure des méthoxyimino-aminothiazol-céphalosporines. Lyon Pharm. 1983;34:99-110.
2. Neu HC. Beta-lactam antibiotics: Structural relationships affecting in vitro activity and pharmacologic properties. Rev Infect Dis. 1986;8:S237-S259.
3. Bergogne-Bérézin E. Les céphalosporines orales. Place du céfuroxime-axetil. Thérapie. 1988;43:343-349.
4. Bingen E, Lambert-Zechovsky N. Relations structures-activité des céphalosporines orales. La Presse Méd. 1989;18:1923-1927.
5. Jones RN. Antimicrobial activity, spectrum and pharmacokinetics of old and new orally administered cephems. Antimicrob News. 1988;5:1-8.
6. Wise R, Andrews JM, Dean S, et al. A pharmacological and in vitro comparison of three oral cephalosporins. J Antimicrob Chemother. 1979;5:601-607.
7. Wise R. The pharmacokinetics of the oral cephalosporins. A review. J Antimicrob Chemother. 1990;26(Suppl E):13-20.
8. Fass RJ, Prior RB. Comparative in vitro activities of oral cephalosporins and competitive antibiotics against recent clinical isolates. Curr Ther Res. 1978;24:352-365.
9. Cullmann W, Dick W, Stieglitz M, Opferkuch W. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods. Role of beta-lactamases on resistance. Chemotherapy. 1988;34:202-215.
10. Wiedemann B, Luhmer E, Zühlsdorf MT. Microbiological evaluation of cefpodoximeproxetil. Drugs. 1991;42(Suppl 3):6-12.
11. Livermore DM. Mechanisms of resistance to cephalosporin antibiotics. Drugs. 1987;34(Suppl 2):64-88.
12. Bergan T. Pharmacokinetic properties of the cephalosporins. Drugs. 1987;34(Suppl 2): 89-104.
13. Borin MT. A review of the pharmacokinetics of cefpodoxime proxetil. Drugs. 1991;42(Suppl 3):13-21.
14. Finch R. Treatment of respiratory tract infections with cephalosporin antibiotics. Drugs. 1987;34(Suppl 2):180-204.
15. Periti P, Novelli A, Schildwachter G, et al. Efficacy and tolerance of cefpodoxime-proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. J Antimicrob Chemother. 1990;26(Suppl E):63-69.
16. Frampton JE, Brogden RN, Langtry HD, Buckley MM. Cefpodoxime-proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs. 1992;44:889-917.
17. Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: Is the difference worth it? Pediatr Infect Dis. 1993;12:268-274.